Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 185

1.

Rivaroxaban plasma levels in acute ischemic stroke and intracerebral hemorrhage.

Seiffge DJ, Kägi G, Michel P, Fischer U, Béjot Y, Wegener S, Zedde M, Turc G, Cordonnier C, Sandor PS, Rodier G, Zini A, Cappellari M, Schädelin S, Polymeris AA, Werring D, Thilemann S, Maestrini I, Berge E, Traenka C, Vehoff J, De Marchis GM, Kapauer M, Peters N, Sirimarco G, Bonati LH, Arnold M, Lyrer PA, De Maistre E, Luft A, Tsakiris DA, Engelter ST; NOACISP study group.

Ann Neurol. 2018 Feb 2. doi: 10.1002/ana.25165. [Epub ahead of print]

PMID:
29394504
2.

Pattern of bleeding in a large prospective cohort of haemophilia A patients: A three-year follow-up of the AHEAD (Advate in HaEmophilia A outcome Database) study.

Khair K, Mazzucconi MG, Parra R, Santagostino E, Tsakiris DA, Hermans C, Oldenburg J, Spotts G, Steinitz-Trost K, Gringeri A.

Haemophilia. 2018 Jan;24(1):85-96. doi: 10.1111/hae.13361. Epub 2017 Oct 17.

PMID:
29044825
3.

Perivascular Perfusion on Contrast-Enhanced Ultrasound (CEUS) Is Associated with Inflammation in Patients with Acute Deep Vein Thrombosis.

Kaspar M, Imfeld S, Partovi S, Aschwanden M, Baldi T, Dikkes A, Vogt DR, Tsakiris DA, Staub D.

Thromb Haemost. 2017 Nov;117(11):2146-2155. doi: 10.1160/TH17-05-0332. Epub 2017 Nov 30.

PMID:
28933797
4.

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN; ESC Scientific Document Group ; ESC Committee for Practice Guidelines (CPG) ; ESC National Cardiac Societies .

Eur Heart J. 2018 Jan 14;39(3):213-260. doi: 10.1093/eurheartj/ehx419. No abstract available.

PMID:
28886622
5.

Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.

Seiffge DJ, Traenka C, Polymeris AA, Thilemann S, Wagner B, Hert L, Müller MD, Gensicke H, Peters N, Nickel CH, Stippich C, Sutter R, Marsch S, Fisch U, Guzman R, De Marchis GM, Lyrer PA, Bonati LH, Tsakiris DA, Engelter ST.

J Stroke. 2017 Sep;19(3):347-355. doi: 10.5853/jos.2017.00395. Epub 2017 Sep 6.

6.

The role of von Willebrand factor in primary haemostasis under conditions of haemodilution.

Jalaer I, Tsakiris DA, Solecka-Witulska BA, Kannicht C.

Thromb Res. 2017 Sep;157:142-146. doi: 10.1016/j.thromres.2017.07.018. Epub 2017 Jul 20.

PMID:
28753477
7.

Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera.

Meyer SC, Steinmann E, Lehmann T, Muesser P, Passweg JR, Skoda RC, Tsakiris DA.

Biomed Res Int. 2017;2017:9876819. doi: 10.1155/2017/9876819. Epub 2017 Jun 18.

8.

Accuracy and consistency of anti-Xa activity measurement for determination of rivaroxaban plasma levels.

Studt JD, Alberio L, Angelillo-Scherrer A, Asmis LM, Fontana P, Korte W, Mendez A, Schmid P, Stricker H, Tsakiris DA, Wuillemin WA, Nagler M.

J Thromb Haemost. 2017 Aug;15(8):1576-1583. doi: 10.1111/jth.13747. Epub 2017 Jul 17.

PMID:
28574652
9.

Impact of a product-specific reference standard for the measurement of a PEGylated rFVIII activity: the Swiss Multicentre Field Study.

Bulla O, Poncet A, Alberio L, Asmis LM, Gähler A, Graf L, Nagler M, Studt JD, Tsakiris DA, Fontana P.

Haemophilia. 2017 Jul;23(4):e335-e339. doi: 10.1111/hae.13250. Epub 2017 May 24.

PMID:
28544263
10.

Impact of rivaroxaban on point-of-care assays.

Fontana P, Alberio L, Angelillo-Scherrer A, Asmis LM, Korte W, Mendez A, Schmid P, Stricker H, Studt JD, Tsakiris DA, Wuillemin WA, Nagler M.

Thromb Res. 2017 May;153:65-70. doi: 10.1016/j.thromres.2017.03.019. Epub 2017 Mar 21.

PMID:
28343143
11.

Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial.

Roger SD, Gaillard CA, Bock AH, Carrera F, Eckardt KU, Van Wyck DB, Cronin M, Meier Y, Larroque S, Macdougall IC; FIND-CKD Study Investigators.

Nephrol Dial Transplant. 2017 Sep 1;32(9):1530-1539. doi: 10.1093/ndt/gfw264.

PMID:
28339831
12.

Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.

Paczulla AM, Dirnhofer S, Konantz M, Medinger M, Salih HR, Rothfelder K, Tsakiris DA, Passweg JR, Lundberg P, Lengerke C.

Haematologica. 2017 May;102(5):854-864. doi: 10.3324/haematol.2016.153528. Epub 2017 Feb 9.

13.

Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.

Macdougall IC, Bock AH, Carrera F, Eckardt KU, Gaillard C, Van Wyck D, Meier Y, Larroque S, Roger SD; FIND-CKD Study investigators.

BMC Nephrol. 2017 Jan 17;18(1):24. doi: 10.1186/s12882-017-0444-6.

14.

Thrombophilia Screening: Universal, Selected, or Neither?

Colucci G, Tsakiris DA.

Clin Appl Thromb Hemost. 2017 Nov;23(8):893-899. doi: 10.1177/1076029616683803. Epub 2017 Jan 4.

PMID:
28049358
15.

Direkte orale Antikoagulantien.

Merki R, Schwarb H, Tsakiris DA.

Ther Umsch. 2016;73(10):613-617. doi: 10.1024/0040-5930/a000834. Review. German. No abstract available.

PMID:
28045365
16.

Feasibility of rapid measurement of Rivaroxaban plasma levels in patients with acute stroke.

Seiffge DJ, Traenka C, Polymeris A, Hert L, Fisch U, Peters N, De Marchis GM, Guzman R, Nickel CH, Lyrer PA, Bonati LH, Tsakiris D, Engelter S.

J Thromb Thrombolysis. 2017 Jan;43(1):112-116. doi: 10.1007/s11239-016-1431-7.

PMID:
27696335
17.

Direct oral anticoagulants in the elderly: systematic review and meta-analysis of evidence, current and future directions.

Sadlon AH, Tsakiris DA.

Swiss Med Wkly. 2016 Sep 28;146:w14356. doi: 10.4414/smw.2016.14356. eCollection 2016.

18.

A Genetic Biomarker of Oxidative Stress, the Paraoxonase-1 Q192R Gene Variant, Associates with Cardiomyopathy in CKD: A Longitudinal Study.

Dounousi E, Bouba I, Spoto B, Pappas K, Tripepi G, Georgiou I, Tselepis A, Elisaf M, Tsakiris D, Zoccali C, Siamopoulos K.

Oxid Med Cell Longev. 2016;2016:1507270. doi: 10.1155/2016/1507270. Epub 2016 May 30.

19.

Heparin-induced thrombocytopenia in pregnancy: an interdisciplinary challenge-a case report and literature review.

Mauermann E, Vökt C, Tsakiris DA, Tobler D, Girard T.

Int J Obstet Anesth. 2016 May;26:79-82. doi: 10.1016/j.ijoa.2015.11.009. Epub 2015 Dec 10. Review.

PMID:
26775898
20.

Inflammation, Endothelial Dysfunction and Increased Left Ventricular Mass in Chronic Kidney Disease (CKD) Patients: A Longitudinal Study.

Ioannou K, Stel VS, Dounousi E, Jager KJ, Papagianni A, Pappas K, Siamopoulos KC, Zoccali C, Tsakiris D.

PLoS One. 2015 Sep 23;10(9):e0138461. doi: 10.1371/journal.pone.0138461. eCollection 2015.

Supplemental Content

Loading ...
Support Center